| Literature DB >> 29326840 |
Heather D Veilleux1, Jennifer M Donelson1,2, Philip L Munday1.
Abstract
Reproduction in marine fish is generally tightly linked with water temperature. Consequently, when adults are exposed to projected future ocean temperatures, reproductive output of many species declines precipitously. Recent research has shown that in the common reef fish, Acanthochromis polyacanthus, step-wise exposure to higher temperatures over two generations (parents: +1.5°C, offspring: +3.0°C) can improve reproductive output in the F2 generation compared to F2 fish that have experienced the same high temperatures over two generations (F1 parents: +3.0°C, F2 offspring: +3.0°C). To investigate how a step-wise increase in temperature between generations improved reproductive capacity, we tested the expression of well-known teleost reproductive genes in the brain and gonads of F2 fish using quantitative reverse transcription PCR and compared it among control (+0.0°C for two generations), developmental (+3.0°C in second generation only), step (+1.5°C in first generation and +3.0°C in second generation), and transgenerational (+3.0°C for two generations) treatments. We found that levels of gonadotropin receptor gene expression (Fshr and Lhcgr) in the testes were reduced in developmental and transgenerational temperature treatments, but were similar to control levels in the step treatment. This suggests Fshr and Lhcgr may be involved in regulating male reproductive capacity in A. polyacanthus. In addition, lower Fshb expression in the brain of females in all temperature treatments compared to control, suggests that Fshb expression, which is involved in vitellogenesis, is sensitive to high temperatures. Our results help elucidate key genes that facilitate successful reproduction in reef fishes when they experience a gradual increase in temperature across generations consistent with the trajectory of climate change.Entities:
Keywords: Acanthochromis polyacanthus; climate change; gonadotropins; qRT-PCR; reproduction; transgenerational plasticity
Year: 2018 PMID: 29326840 PMCID: PMC5757642 DOI: 10.1093/conphys/cox077
Source DB: PubMed Journal: Conserv Physiol ISSN: 2051-1434 Impact factor: 3.079
Figure 1:Experimental design tree showing three generations (F0, F1 and F2) of Acanthochromis polyacanthus. Temperature treatments are colour-coded with filled colours representing temperatures experienced for that generation and borders representing temperatures their parents experienced. Experimental duration for each generation is shown in the vertical dark grey bars to the left and treatments are indicated in the horizontal light grey bars below.
Quantitative reverse transcription PCR (qRT-PCR) brain and gonad target and reference genes, associated forward and reverse primer sequences and expected product length
| Type | Gene | Forward Primer (5′−3′) | Reverse Primer (5′−3′) | Expected product (bp) | |
|---|---|---|---|---|---|
| Brain | Dopa Decarboxylase (an enzyme in the pathway that produces dopamine) | GTCCAGGCAACCAACTCCAG | CCTCCAATCAGAGCAGCTCG | 110 | |
| Follicle Stimulating Hormone, Beta Polypeptide | CACCACCGTGTGTTCAGGAC | ACCTCGTAGGACCAGTCACC | 105 | ||
| Gonadotropin-Releasing Hormone 1 | CTGTCAGCACTGGTCGTATG | ACTGAAGGGTGCGTCCAT | 115 | ||
| Gonadotropin-Releasing Hormone Receptor | TTCCTGCTCCCACTGGTCAT | GAGTCTTCATCCGGGCTCTG | 148 | ||
| Luteinizing Hormone, Beta Polypeptide | AGACGGTGTCTCTGGAGAAG | TACAGGTCCTGGTAGGTGC | 148 | ||
| Gonad | Cytochrome P450, Family 11, Subfamily B, Polypeptide 1 (a.k.a. 11b-hydroxylase) | CAGCACAGCAAGGGAGTCTT | CAGAAATCCCTCGCCACCTC | 137 | |
| Cytochrome P450, Family 19, Subfamily A, Polypeptide 1 (a.k.a arom/aromatase) | CCGGACAGAGTTCTTCCTCA | CGAATGGCTGGAAGTAACGG | 86 | ||
| Follicle Stimulating Hormone Receptor | CCTCTCATCACCGTCTCCGA | CGGGTGAAGAAGGCGTACAG | 95 | ||
| Luteinizing Hormone/Choriogonadotropin Receptor | TGAACCTGGCTAGAAACGGC | AGAACTCGGACCTGTGGCTC | 143 | ||
| Reference | CCR4-NOT Transcription Complex, Subunit 1 | ATCCACAACAAGGGCAGCACCC | TCAGTGTCCAGGTCCACAGCCA | 95 | |
| Dishevelled Segment Polarity Protein 1 | AGTGAATCCGAGCCAGGTGTCC | ACTGTGACTGGAGACGGCATGG | 93 | ||
| SIN3 Transcription Regulator Family Member B | AACAGGGACGCAACGGCTCT | TGGATGGTGGGCTGACGCTT | 133 | ||
| 18s ribosomal RNA | TTGACGGAAGGGCACCACCA | AGAACGGCCATGCACCACCA | 142 | ||
| Eukaryotic Translation Elongation Factor 1 Alpha 1 | ACGCCTGGGTGCTGGACAAA | GCGACAATCAGCACAGCGCA | 183 | ||
Type III analysis of variance (ANOVA) testing differences in brain and gonad gene expression between sexes and/or treatments
| Tissue | Gene | ALL | FEMALE | MALE | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Source | Df | Chisq | Pr(>Chisq) | Source | Df | Chisq | Pr(>Chisq) | Source | Df | Chisq | Pr(>Chisq) | ||
| Brain | (Intercept) | 1 | 14.05 | <0.00 | (Intercept) | 1 | 10.69 | <0.00 | (Intercept) | 1 | 24.58 | <0.00 | |
| Treatment | 3 | 0.94 | 0.82 | Treatment | 3 | 0.71 | 0.87 | Treatment | 3 | 2.84 | 0.42 | ||
| Sex | 1 | 0.86 | 0.35 | ||||||||||
| Treatment:Sex | 3 | 0.42 | 0.94 | ||||||||||
| (Intercept) | 1 | 52.77 | <0.00 | (Intercept) | 1 | 58.63 | <0.00 | (Intercept) | 1 | 35.20 | <0.00 | ||
| Treatment | 3 | 11.45 | Treatment | 3 | 12.72 | Treatment | 3 | 6.02 | 0.11 | ||||
| Sex | 1 | 0.04 | 0.85 | ||||||||||
| Treatment:Sex | 3 | 5.82 | 0.12 | ||||||||||
| (Intercept) | 1 | 5.26 | 0.02 | (Intercept) | 1 | 13.13 | <0.00 | (Intercept) | 1 | 3.52 | 0.06 | ||
| Treatment | 3 | 0.51 | 0.92 | Treatment | 3 | 1.26 | 0.74 | Treatment | 3 | 3.75 | 0.29 | ||
| Sex | 1 | 0.11 | 0.74 | ||||||||||
| Treatment:Sex | 3 | 3.99 | 0.26 | ||||||||||
| (Intercept) | 1 | 6.64 | 0.01 | (Intercept) | 1 | 4.20 | 0.04 | (Intercept) | 1 | 22.48 | <0.00 | ||
| Treatment | 3 | 0.71 | 0.87 | Treatment | 3 | 0.45 | 0.93 | Treatment | 3 | 3.68 | 0.30 | ||
| Sex | 1 | 1.01 | 0.31 | ||||||||||
| Treatment:Sex | 3 | 0.80 | 0.85 | ||||||||||
| (Intercept) | 1 | 21.66 | <0.00 | (Intercept) | 1 | 18.45 | <0.00 | (Intercept) | 1 | 8.51 | <0.00 | ||
| Treatment | 3 | 2.65 | 0.45 | Treatment | 3 | 2.26 | 0.52 | Treatment | 3 | 5.76 | 0.12 | ||
| Sex | 1 | 0.73 | 0.39 | ||||||||||
| Treatment:Sex | 3 | 5.61 | 0.13 | ||||||||||
| Gonad | (Intercept) | 1 | 6.92 | 0.01 | (Intercept) | 1 | 8.27 | <0.00 | (Intercept) | 1 | 124.90 | <0.00 | |
| Treatment | 3 | 4.91 | 0.18 | Treatment | 3 | 5.87 | 0.12 | Treatment | 3 | 4.73 | 0.19 | ||
| Sex | 1 | 60.87 | |||||||||||
| Treatment:Sex | 3 | 7.61 | 0.05 | ||||||||||
| (Intercept) | 1 | 239.33 | <0.00 | (Intercept) | 1 | 519.85 | <0.00 | (Intercept) | 1 | 9.02 | <0.00 | ||
| Treatment | 3 | 0.46 | 0.93 | Treatment | 3 | 1.01 | 0.80 | Treatment | 3 | 1.65 | 0.65 | ||
| Sex | 1 | 46.22 | |||||||||||
| Treatment:Sex | 3 | 2.30 | 0.51 | ||||||||||
| (Intercept) | 1 | 15.52 | <0.00 | (Intercept) | 1 | 9.13 | <0.00 | (Intercept) | 1 | 167.70 | <0.00 | ||
| Treatment | 3 | 0.96 | 0.81 | Treatment | 3 | 0.56 | 0.90 | Treatment | 3 | 9.46 | |||
| Sex | 1 | 2.28 | 0.13 | ||||||||||
| Treatment:Sex | 3 | 0.48 | 0.92 | ||||||||||
| (Intercept) | 1 | 13.30 | <0.00 | (Intercept) | 1 | 8.89 | <0.00 | (Intercept) | 1 | 121.35 | <0.00 | ||
| Treatment | 3 | 6.96 | 0.07 | Treatment | 3 | 4.65 | 0.20 | Treatment | 3 | 10.94 | |||
| Sex | 1 | 9.79 | |||||||||||
| Treatment:Sex | 3 | 10.25 | 0.795 | ||||||||||
Grey fills represent significant results, P < 0.05.
Figure 2:Mean (±SE) log2 brain gene expression (Ddc, Fshb, Lhb, Gnrhr and Gnrh1) for control, developmental, step and transgenerational Acanthochromis polyacanthus treatments. Note: some error bars are too small to be seen. Female samples are denoted with diamonds and males with squares. Gene expression relative to reference genes Cnot1 and Dvl1.
Figure 3:Mean (±SE) log2 gonad gene expression (Cyp11b1, Cyp19a1a, Fshr and Lhcgr) for control, developmental, step and transgenerational Acanthochromis polyacanthus treatments. Note: some error bars are too small to be seen. Female samples are denoted with diamonds and males with squares. Gene expression relative to reference genes Dvl1 and Ef1a.